Michael David Weiss MD

Dr. Michael Weiss is the founding Director of the Division of Neuromuscular Diseases and Professor of Neurology at the University of Washington Medical Center. He completed neurology residency training at Georgetown University and fellowship training in neuromuscular disorders at the University of Maryland and in neurochemistry and neuroimmunology at the National Institutes of Health. He is the co-Director of the UW Muscular Dystrophy Association (MDA) Clinic, co-Director of the Charcot-Marie Tooth disease (CMT) Center of Excellence, and co-Director of the Guillain-Barre syndrome/ Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Center of Excellence. He is also co-Director of the MDA-certified amyotrophic lateral sclerosis (ALS) Center of Excellence.

Dr. Weiss is a fellow of the American Academy of Neurology and the American Neurological Association. He has been on the editorial board of Muscle and Nerve and is an ad hoc reviewer for the Annals of Neurology, Neurology, and Journal of Clinical Neuromuscular Disorders. He has authored or co-authored over 100 journal articles, reviews, and book chapters, primarily focused on neuromuscular diseases.

Dr. Weiss sees patients at the University of Washington-Montlake campus. His clinical interests include the diagnosis and treatment of neuromuscular diseases, including ALS, myasthenia gravis, Guillain-Barré syndrome, CIDP, inflammatory myopathies, myotonic disorders, and muscular dystrophies. In addition to treatment trials of ALS, his current research interests include biomarker studies in ALS and treatment trials for inflammatory myopathies, CMT, and myasthenia gravis.